These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 36592152)
1. Lichen planus pemphigoides after pembrolizumab immunotherapy in an older man. Ee S; Liang MW; Tee SI; Wang DY Ann Acad Med Singap; 2022 Dec; 51(12):804-806. PubMed ID: 36592152 [No Abstract] [Full Text] [Related]
2. Lichen planus pemphigoides during therapy with tislelizumab and sitravatinib in a patient with metastatic lung cancer. Kerkemeyer KLS; Lai FYX; Mar A Australas J Dermatol; 2020 May; 61(2):180-182. PubMed ID: 31808542 [No Abstract] [Full Text] [Related]
3. Lichen Planus Pemphigoides Induced by Camrelizumab in Combination With Lenvatinib. Zhang X; Wang J; Wang H; Qin X; Zhang R Am J Dermatopathol; 2024 May; 46(5):332-333. PubMed ID: 38457682 [No Abstract] [Full Text] [Related]
4. Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma. Schmidgen MI; Butsch F; Schadmand-Fischer S; Steinbrink K; Grabbe S; Weidenthaler-Barth B; Loquai C J Dtsch Dermatol Ges; 2017 Jul; 15(7):742-745. PubMed ID: 28622432 [No Abstract] [Full Text] [Related]
6. Atezolizumab-induced lichen planus pemphigoides in a patient with metastatic non-small-cell lung cancer. Senoo H; Kawakami Y; Yokoyama E; Yamasaki O; Morizane S J Dermatol; 2020 Apr; 47(4):e121-e122. PubMed ID: 31984550 [No Abstract] [Full Text] [Related]
7. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. Zillikens D; Caux F; Mascaro JM; Wesselmann U; Schmidt E; Prost C; Callen JP; Bröcker EB; Diaz LA; Giudice GJ J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629 [TBL] [Abstract][Full Text] [Related]
8. Non-Bullous Lichen Planus Pemphigoides Possibly Induced by Venlafaxine. Tan AJ; Vaidya S Australas J Dermatol; 2016 May; 57(2):154-5. PubMed ID: 27124647 [No Abstract] [Full Text] [Related]
9. Lichen planus pemphigoides with antibodies against the BP180 C-terminal domain induced by pembrolizumab in a melanoma patient. Yoshida S; Shiraishi K; Yatsuzuka K; Mori H; Koga H; Ishii N; Sayama K J Dermatol; 2021 Sep; 48(9):e449-e451. PubMed ID: 34089265 [No Abstract] [Full Text] [Related]
14. Lichen planus pemphigoides associated with Chinese herbs. Xu HH; Xiao T; He CD; Jin GY; Wang YK; Gao XH; Chen HD Clin Exp Dermatol; 2009 Apr; 34(3):329-32. PubMed ID: 18699839 [TBL] [Abstract][Full Text] [Related]
15. Checkpoint inhibitor-induced lichen planus pemphigoides: a case report and literature review of an unusually reported entity. Buján Bonino C; López-Pardo Rico M; Moreiras Arias N; Suárez Peñaranda JM; Casas Fernández L Int J Dermatol; 2023 Apr; 62(4):e200-e204. PubMed ID: 36371713 [No Abstract] [Full Text] [Related]
16. Case of lichen planus pemphigoides after pembrolizumab therapy for advanced urothelial carcinoma. Okada H; Kamiya K; Murata S; Sugihara T; Sato A; Maekawa T; Komine M; Ohtsuki M J Dermatol; 2020 Sep; 47(9):e321-e322. PubMed ID: 32515025 [No Abstract] [Full Text] [Related]
17. Coexisting lichen planus and bullous pemphigoid or lichen planus pemphigoides? Lang PG; Maize JC J Am Acad Dermatol; 1983 Jul; 9(1):133-40. PubMed ID: 6350379 [TBL] [Abstract][Full Text] [Related]
18. Childhood lichen planus pemphigoides: a case report and review of the literature. Cohen DM; Ben-Amitai D; Feinmesser M; Zvulunov A Pediatr Dermatol; 2009; 26(5):569-74. PubMed ID: 19840313 [TBL] [Abstract][Full Text] [Related]
19. Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering. Hübner F; Langan EA; Recke A Front Immunol; 2019; 10():1389. PubMed ID: 31312198 [TBL] [Abstract][Full Text] [Related]